Endo Health Solutions cleared to buy Paladin Labs
US antitrust officials have approved Endo Health Solutions' acquisition of Paladin Labs, a Toronto Stock Exchange-listed specialty-pharmaceutical company. The transaction was cleared Tuesday through a sped-up review process known as 'early...To view the full article, register now.
Already a subscriber? Click here to view full article